Utrogestan in the Second Trimester: Safety & Benefits
Utrogestan (micronized progesterone) is commonly prescribed in the second trimester for specific indications.
Indications
- History of preterm birth: Vaginal progesterone 200 mg nightly from 16–36 weeks reduces recurrent preterm birth (RCT evidence).
- Short cervical length (<25 mm) on transvaginal ultrasound: Vaginal progesterone 200 mg nightly until 36 weeks.
- Luteal phase support (IVF pregnancies): Continued until placental takeover (~10–12 weeks; sometimes extended).
- Threatened preterm labor: Adjunct to tocolysis.
Route
- Vaginal: Preferred; higher uterine concentration, fewer systemic side effects (drowsiness, dizziness).
- Oral: Used if vaginal route not feasible; higher first-pass metabolism.
Safety
- Progesterone is endogenous; micronized form is bioidentical.
- No teratogenicity; large cohorts show no increase in congenital anomalies.
- Side effects: vaginal discharge, irritation, drowsiness (oral), headache, breast tenderness.
Monitoring
- Cervical length surveillance (if indicated).
- Maternal symptoms; fetal growth scans per protocol.
Always follow your obstetrician's specific prescription. Do not self-medicate or discontinue without guidance.
Prescription Medications - Related Articles
- Finacea vs. Azelex: Understanding Acne & Rosacea Treatments
- Diflucan (Fluconazole): Uses, Dosage & Side Effects
- Understanding Antiviral Drugs: How They Work and Their Role in Treatment
- Transferring Your Caremark Prescription to Walmart Pharmacy: A Simple Guide
- Drotaverine (Drotin) Overdose: Cardiac, Respiratory & Neurological Dangers
- Microbes: Their Benefits and Applications in Health, Food & Biotechnology
- Sirtuins, mTOR & Longevity: The Science of Slowing Aging
